An investor webcast and conference call will be held at
About
Contact:
Ms. Kyahn Williamson
Email: kyahn.williamson@telixpharma.com
(C) 2024 Electronic News Publishing, source
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
15.39 AUD | +0.13% | +0.07% | +52.68% |
05:34am | Telix Pharmaceuticals Concludes Proof-of-Concept Study of Advanced Prostate Cancer Drug | MT |
May. 20 | Telix Pharmaceuticals Files Registration Statement for Nasdaq IPO | MT |
An investor webcast and conference call will be held at
About
Contact:
Ms. Kyahn Williamson
Email: kyahn.williamson@telixpharma.com
(C) 2024 Electronic News Publishing, source
1st Jan change | Capi. | |
---|---|---|
+52.68% | 3.43B | |
+44.48% | 54.04B | |
+43.57% | 41.96B | |
-0.86% | 41.92B | |
-7.59% | 28.35B | |
+12.30% | 26.35B | |
-21.83% | 19B | |
+7.15% | 13B | |
+29.40% | 12.28B | |
+25.15% | 12.19B |